From: Autologous bone marrow-derived mononuclear cell therapy in three patients with severe asthma
CD markers | Phenotype | Percentage |
---|---|---|
CD45lowCD34highSSC↓ | Hematopoietic stem cells | 1.83 |
CD45lowCD34+CD19+ | B cell progenitors | 5.6 |
CD45+CD34−CD64+CD14− | Promonocytes | 4.27 |
CD105+CD90highCD73+CD45−CD34− | Mesenchymal stromal cells | 0.07 |
FSC↓SSC↓CD45−CD71+CD36+ | Erythroblasts | 6.46 |
CD45+CD34−CD64+CD14+ | Monocytes | 9.6 |
CD45+CD34−CD3+ | T lymphocytes | 35.53 |
CD45+CD3+CD4+ | Helper T cells | 12.96 |
CD45+CD3+CD8+ | Cytotoxic T cells | 9.46 |
CD45+CD3−CD19+ | B cells | 5.6 |
CD45+CD56+ | NK cells | 4.46 |